Literature DB >> 2020450

Results from the first year of the New Zealand cot death study.

E A Mitchell1, R Scragg, A W Stewart, D M Becroft, B J Taylor, R P Ford, I B Hassall, D M Barry, E M Allen, A P Roberts.   

Abstract

New Zealand's high mortality rate from the sudden infant death syndrome (SIDS) prompted the development of the New Zealand cot death study. This report of the preliminary analysis of the first year of the data gives the major identified risk factors. One hundred and sixty-two infants who died from SIDS were compared with 589 control infants, who were a representative sample of all hospital births in the study region. Obstetric records were examined and parental interviews were completed in 96% and 89% of subjects respectively. Data were available for all the variables in this study in 95% of those interviewed, thus 128 cases and 503 controls make up the subjects of this report. As expected we confirmed many risk factors for SIDS including: lower socioeconomic status, unmarried mother, young mother, younger school leaving age of mother, younger age of mother at first pregnancy, late attendance at antenatal clinic, nonattendant at antenatal classes, Maori, greater number of previous pregnancies, lower birth weight, shorter gestation, male infant, admission to neonatal intensive care unit. In addition, however, we identified three risk factors which are potentially amenable to modification. These were the prone sleeping position of baby (odds ratio = 3.53, 95% confidence interval 2.26, 5.54), maternal smoking (1-9 cigarettes/day OR = 1.87, 95% CI = 0.98, 3.54; 10-19/day OR = 2.64, 95% CI = 1.47, 4.74; 20+/day OR = 5.06, 95% CI = 2.86, 8.95) and breast feeding (OR = 2.93, 95% CI = 1.84, 4.67).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020450

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  47 in total

1.  Use of duvets and the risk of sudden infant death syndrome.

Authors:  E A Mitchell; S M Williams; B J Taylor
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

2.  SIDS, illness, and acute medical care. New Zealand Cot Death Study Group.

Authors:  R P Ford; E A Mitchell; A W Stewart; R Scragg; B J Taylor
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

Review 3.  Sudden unexpected death in infancy and socioeconomic status: a systematic review.

Authors:  N Spencer; S Logan
Journal:  J Epidemiol Community Health       Date:  2004-05       Impact factor: 3.710

4.  Are the risk factors for SIDS different for preterm and term infants?

Authors:  J M D Thompson; E A Mitchell
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

5.  Improved estimates of the benefits of breastfeeding using sibling comparisons to reduce selection bias.

Authors:  Eirik Evenhouse; Siobhan Reilly
Journal:  Health Serv Res       Date:  2005-12       Impact factor: 3.402

6.  Sleep position, autonomic function, and arousal.

Authors:  B C Galland; G Reeves; B J Taylor; D P Bolton
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

7.  Reduction in mortality from sudden infant death syndrome in New Zealand: 1986-92.

Authors:  E A Mitchell; J M Brunt; C Everard
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

8.  Sudden infant death syndrome in New Zealand: are risk scores useful? New Zealand National Cot Death Study Group.

Authors:  S M Williams; B J Taylor; E A Mitchell; R Scragg; R P Ford; A W Stewart
Journal:  J Epidemiol Community Health       Date:  1995-02       Impact factor: 3.710

9.  Are risk factors for sudden infant death syndrome different at night?

Authors:  S M Williams; E A Mitchell; B J Taylor
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

10.  Trends in sudden infant death syndrome in Australia from 1980 to 2002.

Authors:  Edouard Tursan d'Espaignet; Max Bulsara; Luke Wolfenden; Roger W Byard; Fiona J Stanley
Journal:  Forensic Sci Med Pathol       Date:  2007-11-27       Impact factor: 2.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.